Diagnosis of prostate cancer prostate cancer diagnostic imaging. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Neoplastic Cells, Circulating Stromal Cells

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases36

Prostatic Neoplasms Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Adenocarcinoma Disease Progression Neoplasm Metastasis Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Lung Neoplasms Carcinoma Neoplasm Recurrence, Local Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Prostatic Diseases Cell Transformation, Neoplastic Pancreatic Neoplasms Prostatitis Urinary Bladder Neoplasms Colorectal Neoplasms Neovascularization, Pathologic Uterine Cervical Neoplasms Disease Models, Animal Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Rectal Neoplasms Erectile Dysfunction Endometrial Neoplasms Radiation Injuries Precancerous Conditions

Chemicals and Drugs66

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride Metribolone Flutamide RNA, Small Interfering Anticarcinogenic Agents Cancer Vaccines Glutamate Carboxypeptidase II Taxoids DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antigens, Neoplasm Testosterone Congeners Antineoplastic Agents, Phytogenic Testosterone Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Azasteroids Nitriles Phenylthiohydantoin Proto-Oncogene Proteins c-akt Racemases and Epimerases RNA, Neoplasm Tumor Suppressor Protein p53 MicroRNAs Transcription Factors Cholestenone 5 alpha-Reductase Tumor Suppressor Proteins Leuprolide Estramustine Receptor, erbB-2 Goserelin Glutathione S-Transferase pi Antibodies, Monoclonal Receptors, Estrogen DNA-Binding Proteins DNA Primers Proto-Oncogene Proteins Enzyme Inhibitors Oncogene Proteins, Fusion Kallikreins Proto-Oncogene Proteins c-bcl-2 Prostatic Secretory Proteins Androgen-Binding Protein Steroid 17-alpha-Hydroxylase Paclitaxel Insulin-Like Growth Factor Binding Protein 3 Ki-67 Antigen Radiopharmaceuticals Biological Markers Carotenoids Nuclear Proteins Receptor, Epidermal Growth Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Prostatectomy Orchiectomy Early Detection of Cancer Sensitivity and Specificity Neoplasm Staging Neoplasm Grading Prognosis Risk Factors Reverse Transcriptase Polymerase Chain Reaction Retrospective Studies Xenograft Model Antitumor Assays Digital Rectal Examination Prospective Studies Biopsy Case-Control Studies Immunohistochemistry Follow-Up Studies Neoplasm Transplantation Transplantation, Heterologous Gene Expression Profiling Biopsy, Needle Blotting, Western Risk Predictive Value of Tests Risk Assessment Treatment Outcome Transurethral Resection of Prostate Survival Rate Survival Analysis Reproducibility of Results Incidence Cohort Studies Odds Ratio Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis Brachytherapy Combined Modality Therapy Tumor Burden Registries Multivariate Analysis Transfection Disease-Free Survival Tissue Array Analysis SEER Program Antineoplastic Combined Chemotherapy Protocols Logistic Models Early Diagnosis Castration Questionnaires Radiotherapy ROC Curve Kaplan-Meier Estimate Mass Screening Diagnostic Errors Nomograms Molecular Targeted Therapy Radiotherapy Dosage Drug Screening Assays, Antitumor Tomography, X-Ray Computed Radiotherapy, Conformal Delayed Diagnosis Immunoenzyme Techniques Confidence Intervals Diagnostic Imaging Models, Biological Clinical Trials as Topic Flow Cytometry Gene Knockdown Techniques In Situ Hybridization, Fluorescence Disease Models, Animal Enzyme-Linked Immunosorbent Assay Magnetic Resonance Imaging Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Real-Time Polymerase Chain Reaction Proportional Hazards Models Chemotherapy, Adjuvant Positron-Emission Tomography Immunotherapy Genetic Therapy Diagnostic Tests, Routine Genetic Testing Immunoblotting

Psychiatry and Psychology2

Smoking Erectile Dysfunction

Phenomena and Processes43

Gene Expression Regulation, Neoplastic Sensitivity and Specificity Cell Proliferation Genetic Predisposition to Disease Apoptosis Risk Signal Transduction Cell Growth Processes Genotype Drug Resistance, Neoplasm Time Factors Down-Regulation Odds Ratio Cell Division Cell Survival Cell Movement DNA Methylation Transfection Mutation Up-Regulation Polymorphism, Genetic Promoter Regions, Genetic Cell Cycle Dose-Response Relationship, Drug Nomograms Gene Silencing Gene Fusion Base Sequence Genes, Tumor Suppressor Chromosomes, Human, Pair 8 RNA Interference Gene Expression Polymorphism, Single Nucleotide Phosphorylation Diet Alleles Phenotype Transcription, Genetic Genes, Neoplasm Germ-Line Mutation Algorithms Drug Synergism Oncogene Fusion

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Radiotherapy, Conformal Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Algorithms

Named Groups4

African Americans European Continental Ancestry Group Survivors African Continental Ancestry Group

Health Care37

Patient Navigation Sensitivity and Specificity Risk Factors Retrospective Studies Prospective Studies Watchful Waiting Case-Control Studies Follow-Up Studies Risk Predictive Value of Tests Risk Assessment Treatment Outcome Survival Rate Survival Analysis Reproducibility of Results Incidence Cohort Studies Odds Ratio Age Factors Registries Multivariate Analysis Disease-Free Survival SEER Program Logistic Models National Cancer Institute (U.S.)Questionnaires ROC Curve Kaplan-Meier Estimate Mass Screening Diagnostic Errors Nomograms Confidence Intervals Clinical Trials as Topic Proportional Hazards Models Age Distribution Genetic Testing Radiation Injuries

Geographicals4

United States Sweden Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Patient Navigation Prostate Neoplasms Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Early Detection of Cancer Tumor Markers, Biological Adenocarcinoma Disease Progression Neoplasm Metastasis Mice, Nude Prostatic Intraepithelial Neoplasia Sensitivity and Specificity Bone Neoplasms Tosyl Compounds Neoplasm Staging Neoplasm Invasiveness Neoplasm Grading Prognosis Cell Proliferation Risk Factors Genetic Predisposition to Disease Tumor Cells, Cultured Antineoplastic Agents Antineoplastic Agents, Hormonal Reverse Transcriptase Polymerase Chain Reaction Apoptosis Neoplasm Proteins Androgen Receptor Antagonists Retrospective Studies Xenograft Model Antitumor Assays Breast Neoplasms Digital Rectal Examination Prospective Studies Biopsy Anilides Watchful Waiting RNA, Messenger Case-Control Studies Immunohistochemistry Follow-Up Studies Neoplasm Transplantation Dihydrotestosterone Finasteride Transplantation, Heterologous Lung Neoplasms Gene Expression Profiling Carcinoma Biopsy, Needle Blotting, Western Risk Predictive Value of Tests Risk Assessment United States Neoplasm Recurrence, Local Treatment Outcome Transurethral Resection of Prostate Metribolone Survival Rate Survival Analysis Ovarian Neoplasms Signal Transduction Reproducibility of Results Cell Growth Processes Incidence Genotype Drug Resistance, Neoplasm Cohort Studies Prostatic Neoplasms, Castration-Resistant Flutamide RNA, Small Interfering Time Factors Anticarcinogenic Agents Down-Regulation Cancer Vaccines Odds Ratio Polymerase Chain Reaction Glutamate Carboxypeptidase II Colonic Neoplasms Taxoids Cell Division Cell Survival DNA, Neoplasm Mice, SCID 5-alpha Reductase Inhibitors Age Factors Stomach Neoplasms PTEN Phosphohydrolase Oligonucleotide Array Sequence Analysis Brachytherapy Combined Modality Therapy

No FAQ available that match "diagnosis of prostate cancer prostate cancer diagnostic imaging"